Psykey, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CEOS research report →
About the company
Psykey, Inc. is dedicated to the exploration, formulation, and market introduction of specialized ingredients and compounds, including entheogenic, adaptogenic, and nootropic substances. These are incorporated into its functional product lines, which aim to enhance and optimize overall well-being.
- CEO
- Michael Maher
- IPO
- 2006
- Employees
- 6
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $71.78K
- P/E
- 0.55
- P/S
- 0.00
- P/B
- 0.91
- EV/EBITDA
- 0.24
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 733.40%
- ROIC
- -104.59%
- Revenue
- $0 · -100.00%
- Net Income
- $3.12M · 990.68%
- EPS
- $0.01 · 1010.00%
- Op Income
- $-1,958,172
- FCF YoY
- -48.81%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.00
- Beta
- 0.30
- Avg Volume
- 147.31K
Get TickerSpark's AI analysis on CEOS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CEOS coverage
Recent articles, reports, and earnings notes.
No research on CEOS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CEOS report →Similar companies
Peers in the same neighborhood.